HBOT in mega sessions: does it lower necrosis risk

What causes recipient-site necrosis after a hair transplant?

Recipient-site necrosis is an uncommon but feared complication causing permanent scarring and hair loss that further surgery cannot reliably repair. It's vascular: incisions packed too densely over too large an area, in a scalp with compromised circulation, can leave tissue between them without adequate perfusion — worsened by smoking, diabetes or prior scarring.

Recipient-site necrosis is one of the more feared complications in hair transplantation. It is uncommon, but when it occurs it produces permanent scarring and loss of the transplanted area, and it is not something further surgery reliably repairs.

The mechanism is vascular. Every recipient incision is a small injury to the scalp's blood supply. Pack incisions densely enough into an area, over a large enough surface, in a scalp whose circulation is already compromised, and the tissue between the incisions can be left with inadequate perfusion. That is the pathway to necrosis.

The recognised contributors are the ones you would expect: very high recipient-site density, very large single sessions, aggressive tumescence, smoking, poorly controlled diabetes, prior scarring or previous surgery in the same area, and — in some accounts — high adrenaline concentrations causing prolonged vasoconstriction.

Why is HBOT considered a plausible treatment for necrosis risk?

HBOT is a candidate because its oxygen and angiogenesis effects target marginal tissue perfusion, the mechanism behind necrosis. Compromised skin grafts and flaps are a recognised hyperbaric indication, but Thom's review notes the evidence comes largely from animal studies plus few clinical trials — addressing salvage of failing grafts, not prevention in routine cases.

The hypothesis is straightforward. If necrosis arises from marginal perfusion in a tissue bed under stress, then a treatment that raises dissolved oxygen in plasma and promotes angiogenesis is aimed at exactly the right target.

This is not a novel idea in surgery. Compromised skin grafts and flaps appear on the recognised hyperbaric indication list, and hyperbaric oxygen has an established role in salvaging flaps whose perfusion is failing. Thom's review sets out that use directly, while being careful to note that the evidence for compromised grafts and flaps and for ischaemia-reperfusion injury comes largely from animal studies plus a small number of clinical trials, with further study warranted.

So the surgical precedent is real, and it is the strongest general argument for HBOT in this field. It is also, importantly, an argument about salvage — treating a graft or flap that is already in trouble — rather than about prophylaxis in a routine case.

Has HBOT ever been studied for necrosis prevention in hair transplantation?

No published study has examined HBOT for necrosis prevention. Fan's trial randomised only 34 patients — too few to see a rare complication in either arm — and Giardiello's five-patient case report found zero complications, but with no control group that observation carries essentially no information about necrosis risk.

There is no published study of hyperbaric oxygen for necrosis prevention in hair transplantation. Not a trial, not a case series, not a registry analysis.

The reason is partly arithmetic. Fan and colleagues randomised 34 patients. Necrosis is rare enough that a study of that size would be expected to see none in either arm, which makes it useless as an endpoint. Establishing that an intervention reduces a rare complication requires either a very large trial or a large observational dataset, and neither exists here.

The Giardiello case report noted zero complications across five HBOT patients. With five patients and no control group, that observation carries essentially no information about necrosis risk — five uncomplicated hair transplants without any adjunct would also be expected to produce zero cases.

What actually reduces necrosis risk in large hair transplant sessions?

Splitting a very large session across two visits is the primary control, since it reduces vascular stress on the recipient area. Moderating density where risk factors stack, stopping smoking before and after surgery, controlling diabetes beforehand, and planning more conservatively on scalps with prior scarring are the other evidence-based measures.

It is worth naming what actually is known to reduce this risk, because an unproven adjunct is a poor substitute for the measures that have a real basis.

• Do not do a mega session at maximum density in a compromised scalp. This is the primary control. Splitting a very large plan across two sessions is the single most reliable way to reduce vascular stress on the recipient area.
• Moderate density where the risk factors stack. Density is a surgical decision, and a slightly lower density in a smoker or a diabetic patient is a rational trade.
• Stop smoking before and after surgery. Nicotine-driven vasoconstriction is a modifiable factor and one of the few the patient controls directly.
• Control diabetes before booking.
• Take previous surgery seriously. A scalp with prior scarring has an altered blood supply and warrants a more conservative plan.

Should HBOT be trusted as protection against necrosis in a mega session?

No — treat the framing with scepticism, not the treatment. There's a coherent mechanistic argument for HBOT in compromised grafts and flaps, but no evidence it prevents hair-transplant necrosis. A session that needs a hyperbaric chamber to be safe is a session that should be smaller.

If you are being offered HBOT specifically as protection against necrosis in a very large session, the correct response is scepticism about the framing rather than about the treatment.

There is a coherent mechanistic argument and a genuine surgical precedent for hyperbaric oxygen in compromised grafts and flaps. There is no evidence at all that it prevents necrosis after a hair transplant, and there is a real risk that offering it as protection makes an over-aggressive plan feel safer than it is.

A session that needs a hyperbaric chamber to be safe is a session that should be smaller. That is the point worth taking away.

Sources

1. Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plastic and Reconstructive Surgery, 2011;127 Suppl 1:131S-141S. pubmed.ncbi.nlm.nih.gov/21200283
2. Undersea and Hyperbaric Medical Society. Indications for Hyperbaric Oxygen Therapy (approved indications list). uhms.org/resources/hbo-indications.html
3. Fan Z, Gan Y, Qu Q, Wang J, Lunan Y, Liu B, Chen R, Hu Z, Miao Y. The effect of hyperbaric oxygen therapy combined with hair transplantation surgery for the treatment of alopecia. Journal of Cosmetic Dermatology, 2021;20(3):917-921. pubmed.ncbi.nlm.nih.gov/32770782
4. Giardiello F, De Medeiros Quirino L, Brigante R, Chumak M. Hyperbaric Oxygen Therapy for Enhanced Postoperative Recovery in Hair Transplantation. Cureus, 2025;17(12):e99635. doi.org/10.7759/cureus.99635
5. Parsley WM, Perez-Meza D. Review of factors affecting the growth and survival of follicular grafts. Journal of Cutaneous and Aesthetic Surgery, 2010;3(2). jcasonline.com

This article summarises published research and standard clinical practice. It is general educational information, not medical advice, and it does not replace the instructions your own surgical team gives you. Where their guidance differs from anything here, follow theirs.